Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 5Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma 16Leukemia, Myeloid, Acute 16Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 15Lymphoma, Large-Cell, Immunoblastic 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Follicular 14Leukemia 13Neuroblastoma 12Multiple Myeloma 12Lymphoma, B-Cell, Marginal Zone 12Hodgkin Disease 12Myelodysplastic Syndromes 11Leukemia, Myelomonocytic, Chronic 10Breast Neoplasms 10Myeloproliferative Disorders 9Congenital Abnormalities 9Sezary Syndrome 7Ovarian Neoplasms 7Neoplasms, Plasma Cell 7Mycosis Fungoides 7Lymphoma, T-Cell, Cutaneous 7Anemia, Refractory, with Excess of Blasts 7Sarcoma 6Myelodysplastic-Myeloproliferative Diseases 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Accelerated Phase 6

Interventions

romidepsin 8Vincristine 6Cyclophosphamide 6Specimen Handling 5Rituximab 5Biopsy 5fludarabine 4Prednisone 4Methotrexate 4Magnetic Resonance Spectroscopy 4Lactones 4Doxorubicin 4Depsipeptides 4ruxolitinib 3duvelisib 3belinostat 3Nivolumab 3Etoposide 3Dexamethasone 3Cytarabine 3Calcium Dobesilate 3Bortezomib 3Azacitidine 3tazemetostat 2sodium-iodide symporter 2pegaspargase 2merphos 2liposomal doxorubicin 2cemiplimab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, T-Cell × Peripheral Blood Stem Cell Transplantation × Clear all
NCT03259503 2025-11-10

Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1 Completed
50 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡